New Home Sales Jump From Record Low
Sales of new homes surged 27 percent last month, bouncing off the previous
month’s record low and blowing past expectations as better weather and
government incentives boosted sales.
|
New Home Sales Jump From Record Low
Sales of new homes surged 27 percent last month, bouncing off the previous
month’s record low and blowing past expectations as better weather and
government incentives boosted sales.
Cymer has a triple top in place, levels to watch
The stock is down 8.4% today following earnings news last night after market close. The shares have triple topped at the $40 area, suggesting more downside to come. Major support is at the 10-week moving average, last at $35.43. That appears to be a likely downside test target. The 50-week and 200 week moving averages at the $34 area would be next major support. Resistance is currently at $37.62
Tags: Cymer has a triple top in place potential downside ahead
Apple makes fresh lifetime highs, new levels to watch.
S&P reports Apple has the second largest market cap.
Apple is now bigger than Microsoft.
Milestone reached today.
Stockshakers Headlines moving the markets now
Chinese think-tank sees GDP up 9.9 pct this year
South Korea sees bank levy at top of G20 agenda
Greece worries hammer euro, Asian stocks drift
Microsoft profit rises, shares fall
Euro hammered in Asia trade, hits 1-yr low
G20 calls subdued so far for stronger China yuan
India’s Wipro Q4 meets f’cast, cautious on outlook
World Bank chief urges deal on voting power shift
Obama scolds Wall St for resisting reform
U.S. jobless claims fall, inflation stays benign
Thai police pull back after confronting protesters
Rig sinks in Gulf of Mexico, oil spill risk looms
Tags: Stockshakers Headlines moving the markets now, Stockshakers.com Headlines moving the markets now
Stockshakers Top Headlines moving the markets now
Citigroup turns in $4.4 bln Q1 profit
Airline body seeks moves to reopen Europe airspace
Goldman faces possible action from Germany, UK
Wall St opens lower amid Goldman worries
Goldman fraud case hits global stocks
Eli Lilly sees health-reform hit in 2010, 2011
EU/IMF team to look at more Greek austerity-report
Toyota agrees to pay $16.4 mln U.S. fine
Australia blocks NAB bid for AXA unit, clears AMP
World Bank set for capital boost, tough vote talks
Philips beats forecasts, shares at 23-month high
Thai troops guard business zone from protesters
SEC charges Goldman Sachs with defrauding investors about products tied to subprime mortgages.
Tags: GS, SEC charges Goldman Sachs, stockshakers breaking market news
There should be some expected profit taking during Thursdays session, remember Friday is an options expiration day.
FAS is up over 9% in the week since Stockshakers recommended it along with the Indonesian Vectors IDX and TVL up 30%.
Stockshakers News headlines moving the market
China’s strong start to 2010 backs tightening case
Europe shares up on China growth, Roche results
Japan manufacturer mood turns positive-Rtrs
U.S. earnings, China growth propel Asia stocks
Rio Tinto ups iron ore guidance after strong Q1
Roche Q1 sales rise 6 pct, beat forecasts
Nakheel to pay $8.2 bln to creditors in June-paper
Toyota to test all SUVs after Lexus sales halt
Peabody hikes bid for Australia’s Macarthur
Big powers say Iran sanctions talks “constructive”
EU’s Rehn: Greece will not default
Concern for shelter after China quake kills 617
Industry results
Strong: advertising; semiconductors; semiconductor equipment; consumer electronics; computer storage and peripherals; financial services; banks; investment and brokerage banks; railroads
Weak: education services; trading co’s and distributors; health care services; managed care; fertilizer and ag chemicals; specialty consumer services
Solars saw upgrades yesterday most were up today.
To buy or not to buy? You may want to hold on for a minute we think we are due for some (Not sure how much) But some pullback soon. Original S&P 500 Fibs were smashed yesterday. We may not see the 5% pullback we were expecting. After any pullback shows its personality we would go long term on Financials with a small portion of our trading intermediate term resources.
TVL is up 10% Today and up 30% since we pointed it out.
MIPI is extremely speculative so be cautious with this one.
DNDN is a drug company that has the ONLY drug in the pipeline to treat prostate cancer. May 1 is the date they are up for approval.
Much of the anticipation is priced in so if they don’t get it they will drop hard. If they are approved…could be a Moon shot. 10X the investment is not out of the question on that one.
we have been trading it all along the way.
AMZN to $166.
we called GOOG to $588 the other night on Stockshakers.com/blog the next morning it went up $15.00 on the day and hit our target.
Holdings include CREE, PCLN, AMZN, DNDN, LVS, WYNN.
we specialize in VERY short term trade strategies. Long term is less of a strength, but I do see where we are going.
Energy is the next to pop up along with the potential for continued Financial strength. The current political administration needs the economy corrected for them to look effective.
They will stop at nothing to help financials. The International Monetary Fund which really runs the show globally has proposed imposing fees on Financials today. (This could adversely effect them.)
Where we are in the recovery will guide us on where our dollars should go, a key point:
During the last 3 years companies cut and cut to be more efficient. Now that they have cut so deep there is now an optimal return on each transaction with successful companies.
Whats the next step after you have created an efficient product and you optimizing each transaction?
Get more transactions…How do you get them? Advertise!
Marketing and advertising is next!
What was the strongest sector today? Industry Watch Strong: advertising
Advertising is typically the first thing companies cut and the first indications of a corner potentially being turned will be the return of the advertising dollars.
Outdoor and online are first Broadcast follows that and Print trails as last in line.
This indicates where the money will flow as the recovery progresses.
In our retirement account we have predominantly focused on Outdoor advertising.
we will keep you posted on our findings.
Projected Down:
TRMS
X
ISRG
Projected Up:
RIG
ENCO
IDX
AMZN
SNS
R
IDSA
BXC
QLTY
RIMM
JPM
RINO
SAM
XRX
SHOO
Tags: AMZN, BXC, ENCO, IDSA, IDX, JPM, QLTY, R, RIG, RIMM, RINO, SAM, SHOO, SNS, Stockshakers News headlines moving the market - stock market projections for Thursday 04/15/10, XRX
Stockshakers Headlines Moving the Market now
Hu tells Obama: China to make its own call on yuan
Asia shares fall, euro consolidates vs dlr
European shares slip; banks, miners retreat
World leaders meet on nuclear terrorism threat
POSCO raises 2010 sales target after strong Q1
BOJ may revise up CPI view; deflation to drag on
China banks may need $70 bln capital
China Sinopec to pay $4.65 bln for oil sands stake
Infosys cautious on recovery; flags currency risk
Pressure mounts on Thai PM after deadly clashes
U.S. deficit down in first half 2010 - report
ADB sees Asia growing 7.5%, suggests flexible FX
GAM assets up 5 pct in Q1 on low-margin inflows
Molecular Insight mid-stage cancer drug trial positive MIPI - rocket shot in the after hours session
Drug improved symptoms in patients with carcinoid tumors
Shares jump 166 pct in extended trade
Molecular Insight Pharmaceuticals Inc MIPI said data from a mid-stage trial of its cancer drug, Onalta, showed the drug improved symptoms associated with metastatic carcinoid tumors, sending its shares up 58 percent in post-market trade.
The main goal of the trial, which tested the drug in 90 patients with malignant metastatic carcinoid tumors and resistant to conventional treatment, was to evaluate the efficacy of Onalta in relieving symptoms such as severe diarrhea, hot flushes and abdominal pain.
Onalta, also called Yttrium-90 edotreotide, consistently showed a trend toward improvement for each symptom and was statistically significant across all symptoms.
Median progression-free survival and overall survival were 16.3 months and 26.9 months, respectively, the company said.
Carcinoid tumors are a type of cancer that develops in the neuroendocrine system.
The treatment was well-tolerated and had an acceptable adverse event profile, with 10 percent of the patients discontinuing treatment because of adverse events.
About 13 percent of the patients experienced adverse events that required a dosage adjustment or interruption of the treatment.
Shares of Molecular Insight rose to $4 in trading after the bell. They closed at $1.50 Monday on Nasdaq.
Tags: MIPI, Molecular Insight mid-stage cancer drug trial positive rocket shot in the after hours session
Markets are setting up for a down day Tuesday based purely off internals.
The next major Fib retracement point for the S&P 500 is less than 2% away. 1229 would be the .618 Fib RT
Many strong momentum stocks had inside days today and looking weak at the top, Very little conviction
from the buyers.
10 year note keeps inching up and flirting with the dangerous 4% range. Up 11/32 on Mondays session to 3.84%.
Dollar weakening and dipping below the 50DMA, commodities seeing a lift, the EURO will benefit from Dollar weakness here.
AMZN may level off here near the highs from Decemeber before continuing with the up momentum move to $166.
GOOG - Forming a bullish pattern here and may try for $588 again soon.
AAPL - Light volume, may retrace a bit. I remain bullish on AAPL long term.
GS - Target $188
Watching: CREE, LCC, FINL, SAH, DFZ
Trying some new scans for daily trades (Very short term and high risk…watching for scan results)
Rolling Bullish stock scan for possible bounce candidates for the DAY Tuesday 041310
JAZZ 11.41
VHC 5.08
SVA 5.80
HTCH 6.34
APT 2.40
ABVT 49.64
ARAY 6.19
ATAC 18.40
AVII 1.23
BTM 19.24
CRNT 10.75
CTFO 7.08
DSTI 0.35
EEV 9.37
FALC 3.44
FBCM 4.71
FTEK 7.70
GRS 7.69
HEAT 9.93
KONG 8.24
MTH 20.24
OPTR 11.85
OREX 5.73
PESI 2.12
SCO 11.85
SPWRA 18.32
VISN 4.96
ZSL 3.77
|
stocks, banks, wall street, news, cash, stock tips, deals, equity, financial settlement, free stock info, free stock pick, global economy, loan, loans, market facts, market projections, money, daytrading, settlement, short term investments, stock tip, structured settlements, trading, trend, watch lists |
Recent Comments